Avitar (Avitar) Change In Receivables : $0.16 Mil (TTM As of Dec. 2007)

View and export this data going back to 1992. Start your Free Trial

What is Avitar Change In Receivables?

Avitar's change in receivables for the quarter that ended in Dec. 2007 was $0.06 Mil. It means Avitar's Accounts Receivable declined by $0.06 Mil from Sep. 2007 to Dec. 2007 .

Avitar's change in receivables for the fiscal year that ended in Sep. 2007 was $0.33 Mil. It means Avitar's Accounts Receivable declined by $0.33 Mil from Sep. 2006 to Sep. 2007 .

Avitar's Accounts Receivable for the quarter that ended in Dec. 2007 was $0.17 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Avitar's Days Sales Outstanding for the three months ended in Dec. 2007 was 31.26.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Avitar's liquidation value for the three months ended in Dec. 2007 was $-12.31 Mil.

Avitar Change In Receivables Historical Data

The historical data trend for Avitar's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avitar Change In Receivables Chart

Avitar Annual Data

Trend

Sep98

Sep99

Sep00

Sep01

Sep02

Sep03

Sep04

Sep05

Sep06

Sep07

Change In Receivables

Get a 7-Day Free Trial

0.45

-0.12

0.06

-0.02

0.33

Avitar Quarterly Data
	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07
Change In Receivables	Get a 7-Day Free Trial															0.23	0.14	-	-0.04	0.06

Avitar Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

Avitar (OTCPK:AVTI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Avitar's Days Sales Outstanding for the quarter that ended in Dec. 2007 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.173	/	0.505	*	91
=	31.26

2. In Ben Graham's calculation of liquidation value, Avitar's accounts receivable are only considered to be worth 75% of book value:

Avitar's liquidation value for the quarter that ended in Dec. 2007 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.003	-	12.551	+	0.75 * 0.173	+	0.5 * 0.225
=	-12.31

Avitar Change In Receivables Related Terms

Thank you for viewing the detailed overview of Avitar's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Avitar (Avitar) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avitar Inc (OTCPK:AVTI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

5005 Elbow Drive SW, Suite 207, Calgary, AB, CAN, T2S 1T9

Website

Avitar Inc, through its subsidiary Avitar Technologies, develops, manufactures, and markets products for oral fluid diagnostics, disease and clinical testing, and wound treating.